Access the full text.
Sign up today, get DeepDyve free for 14 days.
G. Rindi, M. Falconi, C. Klersy, L. Albarello, L. Boninsegna, M. Büchler, C. Capella, M. Caplin, A. Couvelard, C. Doglioni, G. Fave, L. Fischer, G. Fusai, W. Herder, H. Jann, P. Komminoth, R. Krijger, S. Rosa, T. Luong, U. Pape, A. Perren, P. Ruszniewski, Alessandra Scarpa, A. Schmitt, E. Solcia, B. Wiedenmann (2012)
TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study.Journal of the National Cancer Institute, 104 10
S. Scappaticci, M. Brandi, E. Capra, M. Cortinovis, P. Maraschio, M. Fraccaro (1992)
Cytogenetics of multiple endocrine neoplasia syndrome. II. Chromosome abnormalities in an insulinoma and a glucagonoma from two subjects with MEN1.Cancer genetics and cytogenetics, 63 1
Methods in solid tumors
F. Micci, Lisbeth Haugom, T. Ahlquist, H. Andersen, V. Abeler, B. Davidson, C. Tropé, R. Lothe, S. Heim (2010)
Genomic aberrations in borderline ovarian tumorsJournal of Translational Medicine, 8
Ernst Speel, J. Richter, Holger Moch, Carole Egenter, P. Saremaslani, Katrin Rütimann, Jianming Zhao, A. Barghorn, J. Roth, Philipp Heitz, P. Komminoth (1999)
Genetic differences in endocrine pancreatic tumor subtypes detected by comparative genomic hybridization.The American journal of pathology, 155 6
V. Fendrich, D. Bartsch (2011)
Surgical treatment of gastrointestinal neuroendocrine tumorsLangenbeck's Archives of Surgery, 396
P. Long, R. Hruban, R. Lo, C. Yeo, L. Morsberger, C. Griffin (1994)
Chromosome analysis of nine endocrine neoplasms of the pancreas.Cancer genetics and cytogenetics, 77 1
A. Kallioniemi, O. Kallioniemi, D. Sudar, D. Rutovitz, J. Gray, F. Waldman, D. Pinkel (1992)
Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.Science, 258 5083
F. Mitelman, B. Johansson, F. Mertens (2014)
Mitelman database of chromosome aberrations and gene fusions in cancer
G. Capurso, S. Festa, R. Valente, M. Piciucchi, F. Panzuto, R. Jensen, G. Fave (2012)
Molecular pathology and genetics of pancreatic endocrine tumours.Journal of molecular endocrinology, 49 1
Y. Jonkers, S. Claessen, A. Perren, Sonja Schmid, P. Komminoth, A Verhofstad, L. Hofland, R. Krijger, Piet Slootweg, F Ramaekers, Ernst Speel (2005)
Chromosomal instability predicts metastatic disease in patients with insulinomas.Endocrine-related cancer, 12 2
F. Bosman (2010)
WHO Classification of Tumours of the Digestive System
L. Boninsegna, F. Panzuto, S. Partelli, P. Capelli, G. Fave, R. Bettini, P. Pederzoli, A. Scarpa, M. Falconi (2012)
Malignant pancreatic neuroendocrine tumour: lymph node ratio and Ki67 are predictors of recurrence after curative resections.European journal of cancer, 48 11
O. Hauso, B. Gustafsson, M. Kidd, H. Waldum, I. Drozdov, Anthony Chan, I. Modlin (2008)
Neuroendocrine tumor epidemiologyCancer, 113
G. Rindi, B. Wiedenmann (2012)
Neuroendocrine neoplasms of the gut and pancreas: new insightsNature Reviews Endocrinology, 8
B. Terris, A. Bernheim (1999)
[Comparative genomic hybridization (CGH): application to the study of neuroendocrine tumors].Annales de pathologie, 19 5 Suppl
Jianming Zhao, H. Moch, Alexander Scheidweiler, A. Baer, A. Schäffer, E. Speel, J. Roth, P. Heitz, P. Komminoth (2001)
Genomic imbalances in the progression of endocrine pancreatic tumorsGenes, 32
James Yao, Manal Hassan, A. Phan, Cecile Dagohoy, C. Leary, J. Mares, E. Abdalla, J. Fleming, J. Vauthey, A. Rashid, Douglas Evans (2008)
One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 18
Ernst Speel, Alexander Scheidweiler, Jianming Zhao, Claudia Matter, P. Saremaslani, J. Roth, Philipp Heitz, P. Komminoth (2001)
Genetic evidence for early divergence of small functioning and nonfunctioning endocrine pancreatic tumors: gain of 9Q34 is an early event in insulinomas.Cancer research, 61 13
S. Haugvik, I. Marangos, B. Røsok, Ewa Pomianowska, I. Gladhaug, Ø. Mathisen, B. Edwin (2013)
Long-Term Outcome of Laparoscopic Surgery for Pancreatic Neuroendocrine TumorsWorld Journal of Surgery, 37
Maria Bugalho, L. Roque, L. Sobrinho, A. Hoog, J. Nunes, J. Almeida, C. Leitão, J. Santos, M. Pereira, M. Santos (1994)
Calcitonin‐producing insulinoma: clinical, immunocytochemical and cytogenetical studyClinical Endocrinology, 41
F. Micci, M. Teixeira, Lisbeth Haugom, G. Kristensen, V. Abeler, S. Heim (2004)
Genomic aberrations in carcinomas of the uterine corpusGenes, 40
G. Floridia, G. Grilli, M. Salvatore, C. Pescucci, P. Moore, A. Scarpa, D. Taruscio (2005)
Chromosomal alterations detected by comparative genomic hybridization in nonfunctioning endocrine pancreatic tumors.Cancer genetics and cytogenetics, 156 1
The pathogenesis of sporadic pancreatic neuroendocrine neoplasms (PNENs) is poorly understood. To gain insight into the genetic mechanisms underlying this tumor entity, we performed genome-wide screening of 16 surgical specimens from 15 patients with sporadic PNEN, combining G-band karyotyping and high resolution comparative genomic hybridization (HR-CGH). G-banding revealed abnormal karyotypes in 2 of 10 tumor samples analyzed. DNA copy number changes were detected in 13 samples, whereas three tumors showed a balanced genome. Gains were more frequent than losses in the nonfunctioning tumors (n=13). Common gains were scored at 5p12-13, 4q13-24, 5p15, 5q11-31, and 9q21-22. Common losses were scored at 11p11, 11p14-15, 11q23, 11p12-13, and 11q22. The average number of copy aberrations (ANCA index) was 12 for 13 nonfunctioning primary tumors, 4.8 for the nonfunctioning tumors with low Ki-67 (≥5%), 21.2 for the tumors with high Ki-67 (<5%), 2.5 for small tumors (<3.5 cm), and 17.8 for large tumors (≥3.5 cm). There was a statistically significant difference in the ANCA index between the groups defined by Ki-67 and tumor size. Nonfunctioning tumors with low Ki-67, no distant metastasis and small size had few aberrations detected by HR-CGH, but frequent loss of material from chromosomal band 11p11. The present study indicates the existence of distinct cytogenetic patterns in sporadic nonfunctioning PNEN. Loss of chromosomal band 11p11 might indicate a primary pathogenetic event in these tumors.
Oncology Reports – Spandidos Publications
Published: Sep 1, 2014
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.